The changing role of axillary lymph node dissection for breast cancer

Breast Cancer

Volumn 20, Issue 1, 2013, Pages 41-46

  Noguchi, Masakuni ^a   Morioka, Emi ^a   Ohno, Yukako ^a   Noguchi, Miki ^a   Nakano, Yasuharu ^a   Kosaka, Takeo ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

ACOSOG Z0011; Axillary lymph node dissection; Breast cancer; Sentinel lymph node biopsy

Indexed keywords

AXILLARY LYMPH NODE; AXILLARY LYMPH NODE EXTIRPATION; BREAST CANCER; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; FALSE NEGATIVE RESULT; HUMAN; LYMPH NODE DISSECTION; MICROMETASTASIS; PARTIAL MASTECTOMY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; SENTINEL LYMPH NODE BIOPSY; SENTINEL LYMPH NODE METASTASIS;

AXILLA; BREAST NEOPLASMS; CLINICAL TRIALS AS TOPIC; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; SENTINEL LYMPH NODE BIOPSY; TUMOR BURDEN;

EID: 84872596055     PISSN: 13406868     EISSN: 18804233     Source Type: Journal    
DOI: 10.1007/s12282-012-0416-4     Document Type: Review

References (43)

1. Fisher B, Redmond C, Fisher ER, Bauer M, Wolmark N, Wickerham DL, et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med. 1985;312:674-81. (Pubitemid 15134703)
2. Fisher B, Jeong JH, Anderson S, Bryant J, Fisher ER, Wolmark N. Twenty-five year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med. 2002;347:567-75.
3. Noguchi M, Miwa K, Michigishi T, Yokoyama K, Nishijima H, Takanaka T, et al. The role of axillary lymph node dissection in breast cancer management. Breast Cancer. 1997;4:143-53.
4. Giuliano AE, Dale PS, Turner RR, Morton DL, Evans SW, Krasne DL. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg. 1995;222:394-401.
5. Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Costantino JP, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 2010;11:927-33.
6. Veronesi U, Viale G, Paganelli G, Zurrida S, Luini A, Galimberti V, et al. Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study. Ann Surg. 2010;251:595-600.
7. Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, Blumencranz PW, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011;305:569-75.
8. Giuliano AE, McCall L, Beitsch P, Whitworth PW, Blumencranz P, Leitch AM, et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg. 2011;252:426-32.
9. Morrow M, Giuliano AE. To cut is to cure: can we really apply Z11 in practice? Ann Surg Oncol. 2011;18:2413-5.
10. Gnant M, Harbeck N, Thomssen C. St. Gallen 2011: summary of the consensus conference. Breast Care. 2011;2011(6):136-41.
11. Halsted W. The results of operations for cure of cancer of the breast performed at Johns Hopkins Hospital. Johns Hopkins Hosp Bull. 1895;4:497.
12. Halsted W. The results of radical operations for the cure of carcinoma of the breast. Ann Surg. 1907;46:1019.
13. Noguchi M. Does regional treatment improve the survival in patients with operable breast cancer? Breast Cancer Res Treat. 2002;76:269-82. (Pubitemid 35335216)
14. Orr RK. The impact of prophylactic axillary node dissection on breast cancer survival: a Bayesian meta-analysis. Ann Surg Oncol. 1999;6:109-66. (Pubitemid 29077496)
15. Hayward JL. The Guy's Hospital trials on breast conservation. In: Harris JR, Hellman S, Silen W, editors. Conservative management of breast cancer. Philadelphia: J.B. Lippincott; 1983. p. 77-90.
16. Hayward J, Caleffi M. The significance of local control in the primary treatment of breast cancer. Arch Surg. 1987;122:1244-7. (Pubitemid 18021275)
17. Hayward JL. The Guy's trial of treatment of "early" breast cancer. World J Surg. 1977;1:314-6. (Pubitemid 8180478)
18. Cady B, Stone MD, Schuler JG, Thakur R, Wanner MA, Lavin PT. The new era in breast cancer. Invasion, size, and nodal status involvement dramatically decreasing as result of mammographic screening. Arch Surg. 1996;131:301-8. (Pubitemid 26078817)
19. Morrow M. Axillary dissection: when and how radical? Semin Surg Oncol. 1996;12:321-7. (Pubitemid 26300010)
20. Noguchi M, Katev N, Miyazaki I. Diagnosis of axillary lymph node metastases in patients with breast cancer. Breast Cancer Res Treat. 1996;40:283-93. (Pubitemid 26336124)
21. Rubio IT. Positive sentinel lymph node: new controversies regarding axillary node dissection. J Surg Oncol. 2006;93:517-8. (Pubitemid 43806983)
22. Reynolds C, Mick R, Donohue JH, Grant CS, Farley DR, Callans LS, et al. Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer. J Clin Oncol. 1999;17:1720-6. (Pubitemid 29269240)
23. Noguchi M. Avoidance of axillary lymph node dissection in selected patients with node-positive breast cancer. Eur J Surg Oncol. 2008;34:129-34.
24. Singletary SE, Greene FL. Revision of breast cancer staging: the 6th edition of the TNM classification. Semi Surg Oncol. 2003;21:53-9. (Pubitemid 37127474)
25. Noguchi M. Therapeutic relevance of breast cancer micrometastases in sentinel lymph nodes. Br J Surg. 2002;89:1505-15. (Pubitemid 35404317)
26. Cserni G, Gregori D, Merletti F, Sapino A, Mano MP, Ponti A, et al. Meta-analysis of non-sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer. Br J Surg. 2004;91:1245-52. (Pubitemid 39331448)
27. Bilimoria KY, Bentrem DJ, Hansen NM, Bethke KP, Rademaker AW, Ko CY, et al. Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection of node-positive breast cancer. J Clin Oncol. 2009;27:2946-53.
28. Hansen NM, Grube B, Ye X, Turner RR, Brenner RJ, Sim MS, et al. Impact of micrometastases in the sentinel node of patients with invasive breast cancer. J Clin Oncol. 2009;27:4679-84.
29. Hwang RF, Krishnamurthy S, Hunt KK, Mirza N, Ames FC, Feig B, et al. Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer. Ann Surg Oncol. 2003;10:248-54. (Pubitemid 40486957)
30. Degnim AC, Kriffith KA, Newman L. Clinicopathologic features of metastasis in non sentinel lymph nodes of breast carcinoma patients: a metaanalysis. Cancer. 2003;98:2307-15. (Pubitemid 37466644)
31. Van Zee KJ, Manasseh DM, Bevilacqua JL, Boolbol SK, Fey JV, Tan LK, et al. A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol. 2003;10:1140-51. (Pubitemid 40486808)
32. Coutant C, Olivier C, Lambaudie E, Fondrinier E, Marchal F, Guillemin F, et al. Comparison of models to predict nonsentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: a prospective multicenter study. J Clin Oncol. 2009;27:2800-8.
33. Park J, Fey JV, Naik AM, Borgen PI, Van Zee KJ, Cody HS. A declining rate of completion axillary dissection in sentinel lymph node-positive breast cancer patients is associated with the use of a multivariate nomogram. Ann Surg. 2007;245:462-8. (Pubitemid 46673143)
34. Naik AM, Fey J, Gemignani M, Heerdt A, Montgomery L, Petrek J, et al. The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 procedures. Ann Surg. 2004;240:462-8. (Pubitemid 39121340)
35. Hwang RF, Gonzalez-Angulo AM, Yi M, Buchholz TA, Meric-Bernstan F, Kuerer HM, et al. Low locoregional failure rates in selected breast cancer patients with tumor-positive sentinel lymph nodes who do not undergo completion axillary dissection. Cancer. 2007;110:723-30. (Pubitemid 47257646)
36. Galimberti V, Botteri E, Chifu C, Gentilini O, Luini A, Intra M, et al. Can we avoid axillary dissection in the micrometastatic sentinel node in breast cancer? Breast Cancer Res Treat. 2012;131:819-25.
37. Straver ME, Meijnen P, van Tienhoven G, van de Velde CJH, Mansel RE, Bogaerts J, et al. Sentinel node identification rate and nodal involvement in the EORTC 10981-22023 AMAROS trial. Ann Surg Oncol. 2010;17:1854-61.
38. Cody HS III, Houssami N. Axillary management in breast cancer: what's new for 2012? Breast. 2012;21:411-5.
39. Pazaiti A, Fentiman IS. Which patients need an axillary clearance after sentinel node biopsy? Int J Breast Cancer. 2011. doi: 10.4061/2011/195892.
40. McGhan LJ, Dueck AC, Gray RI, Wasif N, McCullough AE, Pockaj BA. The changing landscape of axillary surgery: which breast cancer patients may still benefit from complete axillary lymph node dissection? J Surg Oncol. 2011. doi: 10.1002/jso.22131.
41. Turner RR, Giuliano AE. Intraoperative pathologic examination of the sentinel lymph node. Ann Surg Oncol. 1999;5:670-2.
42. Chao C, Wong SL, Ackermann D, Simpson D, Carter MB, Brown CM, et al. Utility of intraoperative frozen section analysis of sentinel lymph nodes in breast cancer. Am J Surg. 2001;182:609-15. (Pubitemid 34142680)
43. Noguchi M. Is axillary dissection unnecessary in patients with a positive sentinel lymph node? Breast Cancer. 2012. doi: 10.1007/s12282-012-0351-4.